Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
196 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- John L Mcclellan Memorial Veterans Hospital
Little Rock, Arkansas, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- Los Angeles General Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Usc Norris Oncology/hematology-Newport Beach
Newport Beach, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Keck Medical Center of Usc Pasadena
Pasadena, California, United States
- Smilow Cancer Center/yale-New Haven Hospital
New Haven, Connecticut, United States
- Yale University
New Haven, Connecticut, United States
- Orlando Health Cancer Institute
Orlando, Florida, United States
- Northside Hospital
Atlanta, Georgia, United States
- Augusta University Medical Center
Augusta, Georgia, United States
- Rush-Copley Medical Center
Aurora, Illinois, United States
- Illinois Cancercare-Bloomington
Bloomington, Illinois, United States
- Osf Saint Joseph Medical Center
Bloomington, Illinois, United States
- Illinois Cancercare-Canton
Canton, Illinois, United States
- Memorial Hospital of Carbondale
Carbondale, Illinois, United States
- Illinois Cancercare-Carthage
Carthage, Illinois, United States
- Centralia Oncology Clinic
Centralia, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- University of Illinois
Chicago, Illinois, United States
- Carle at the Riverfront
Danville, Illinois, United States
- Cancer Care Specialists of Illinois - Decatur
Decatur, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Carle Physician Group-Effingham
Effingham, Illinois, United States
- Crossroads Cancer Center
Effingham, Illinois, United States
- Illinois Cancercare-Eureka
Eureka, Illinois, United States
- Illinois Cancercare-Galesburg
Galesburg, Illinois, United States
- Western Illinois Cancer Treatment Center
Galesburg, Illinois, United States
- Illinois Cancercare-Kewanee Clinic
Kewanee, Illinois, United States
- Illinois Cancercare-Macomb
Macomb, Illinois, United States
- Carle Physician Group-Mattoon/charleston
Mattoon, Illinois, United States
- Ssm Health Good Samaritan
Mount Vernon, Illinois, United States
- Uc Comprehensive Cancer Center at Silver Cross
New Lenox, Illinois, United States
- Cancer Care Center of O'Fallon
O'Fallon, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2015
- Primary completion
- 1 Jun 2022
- Completion
- 26 Jan 2027
- Last update posted
- 28 May 2026
- Registered enrollment
- 53
- Registry id
- NCT02143414
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.